Different inflammatory signatures in Alzheimer’s disease and frontotemporal dementia cerebrospinal fluid

Manuscript Number: 

20-1565R2

Author(s): 
Daniel Alcolea, Gustaf Boström, RoseMarie Brundin, Eva Freyhult, Vilmantas Giedraitis, Martin Ingelsson, Lena Kilander, Kim Kultima, Alberto Lleó, Malin Löwenmark, Markus Otto, Hayrettin Tumani, Johan Virhammar, Christine A.F. von Arnim

Disclosures

Daniel Alcolea

  • Consulting Fees:
    I participated in advisory boards from Fujirebio-Europe and Roche Diagnostics
    Lecture Fees:
    I have received speaker honoraria from Fujirebio-Europe, Roche Diagnostics, Nutricia and from Krka Farmacéutica S.L.
    Patents/Royalties
    I declare a filed patent application (WO2019175379 A1 Markers of synaptopathy in neurodegenerative disease).

Gustaf Boström

  • Nothing to Disclose

RoseMarie Brundin

  • Nothing to Disclose

Eva Freyhult

  • Nothing to Disclose

Vilmantas Giedraitis

  • Nothing to Disclose

Martin Ingelsson

  • Consulting Fees:
    I am advisory board member for BioArctic. I receive about 20 000-30 000 SEK/year (2-3 000 Euro/year).

Lena Kilander

  • Nothing to Disclose

Kim Kultima

  • Nothing to Disclose

Alberto Lleó

  • Nothing to Disclose

Malin Löwenmark

  • Nothing to Disclose

Markus Otto

  • Consulting Fees:
    Member of advisory board for Axon, Biogen, Alector

Hayrettin Tumani

  • Lecture Fees:
    Lectures on Multiple sclerosis diagnostics and therapy not related to the content of this paper.
    Grants
    • Agency: 
      Genzyme
      Dates: 
      2018-2020

Johan Virhammar

  • Nothing to Disclose

Christine A.F. von Arnim

  • Consulting Fees:
    CAFvA received honoraria from serving on the scientific advisory board of Biogen, Roche, and Dr. Willmar Schwabe GmbH &Co. KG
    Lecture Fees:
    Funding for travel and speaker honoraria from Biogen, Roche diagnostics AG and Dr. Willmar Schwabe GmbH &Co. KG.
    Grants
    • Agency: 
      Roche diagnostics
      Dates: 
      04/20/2020